Wuhan General Group (China), Inc. (WUHN)

Market Cap	16.55K -99.9%
Revenue (ttm)	80.38M -37.0%
Net Income	-11.32M
EPS	-0.35
Shares Out	55.15M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	14,021
Open	0.0003
Previous Close	0.0005
Day's Range	0.0003 - 0.0003
52-Week Range	0.0000 - 0.0005
Beta	-3.55
RSI	51.97
Earnings Date	n/a

About WUHN

Wuhan General Group (China), Inc., a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Reno, Nevada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Jeffrey Robinson
• Employees: 700
• Stock Exchange: OTCMKTS
• Ticker Symbol: WUHN

Financial Performance

In 2012, WUHN's revenue was $80.38 million, a decrease of -36.96% compared to the previous year's $127.50 million. Losses were -$11.32 million, 146.8% more than in 2011.